GKOS.NYSEGlaukos CORP

Form 4: Glaukos Corp Executive Gains Shares Through Option Vesting and Disposes of Shares for Tax Obligations

Sentiment:

SEC Form 4 Filing


Joseph E. Gilliam, President & COO of Glaukos Corporation, acquired shares through option vesting and disposed of shares to cover tax obligations on vested restricted stock units.

Summary

  • On April 1, 2024, Joseph E. Gilliam, President & COO of Glaukos Corporation, engaged in transactions involving Glaukos Corp [GKOS] common stock.
  • Gilliam disposed of 1,964 shares of common stock at a price of $93.1 per share to cover tax withholding obligations related to vesting restricted stock units.
  • He also acquired 13,721 shares through the vesting of a stock option granted on March 24, 2022, at an exercise price of $55.18.
  • This option vested based on the achievement of the second-year performance goal as determined by the Compensation, Nominating & Governance Committee on April 1, 2024.
  • Following these transactions, Gilliam directly owns 101,845 shares of Glaukos Corp.
  • This includes 76,419 unvested restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of options suggests performance goals were met, but the sale of shares for tax obligations is a neutral event.

Positives

  • The vesting of stock options indicates that the company achieved certain performance goals, as determined by the Compensation, Nominating & Governance Committee.
  • The executive's continued holding of a significant number of shares (101,845) suggests confidence in the company's future performance.

Negatives

  • The disposal of shares to cover tax obligations, while common, slightly reduces the executive's holdings.

Risks

  • Future vesting of restricted stock units and stock options could lead to further dilution of existing shareholders' equity.
  • Executive compensation is tied to performance goals, and failure to meet these goals in the future could impact executive motivation and retention.

Industry Context

Executive compensation through stock options and restricted stock units is a common practice in publicly traded companies to align management's interests with those of shareholders. The vesting of these instruments is often tied to performance metrics, incentivizing executives to achieve specific goals.

Comparison to Industry Standards

  • Stock-based compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors, to attract and retain top talent.
  • Companies like Alcon and Johnson & Johnson, which also operate in the ophthalmic space, utilize similar compensation strategies.
  • The specific terms of the stock options and restricted stock units, such as vesting schedules and performance metrics, are typically benchmarked against industry peers to ensure competitiveness.

Stakeholder Impact

  • Shareholders may view the vesting of stock options positively, as it indicates the achievement of performance goals.
  • Employees may be motivated by the potential for similar equity-based compensation.

Key Dates

DateDescription
03/18/2021Date of original grant of restricted stock units that vested on 04/01/2024.
03/24/2022Date of original grant of stock option to purchase shares of common stock.
04/01/2024Date of transaction: disposal of shares for tax obligations and acquisition of shares through option vesting; Compensation Committee determination of performance goal achievement.
04/03/2024Date of filing of Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.